282 related articles for article (PubMed ID: 15993276)
1. Gain of 9p due to an unbalanced rearrangement der(9;18): a recurrent clonal abnormality in chronic myeloproliferative disorders.
Bacher U; Haferlach T; Schoch C
Cancer Genet Cytogenet; 2005 Jul; 160(2):179-83. PubMed ID: 15993276
[TBL] [Abstract][Full Text] [Related]
2. Leukemic recombinations involving heterochromatin in myeloproliferative disorders with t(1;9).
Sambani C; La Starza R; Pierini V; Vandenberghe P; Gonzales-Aguilera JJ; Rigana H; Koumbi D; Manola KN; Stavropoulou C; Georgakakos VN; Pagoni M; Wlodarska I; Mecucci C
Cancer Genet Cytogenet; 2005 Oct; 162(1):45-9. PubMed ID: 16157199
[TBL] [Abstract][Full Text] [Related]
3. Is the gain of 9p involved in the pathogenesis of polycythemia vera? A purpose of a case.
Zamora L; Lloveras E; Espinet B; Muñoz C; Perez C; Plaja A
Haematologica; 2002 Jan; 87(1):ECR05. PubMed ID: 11801479
[No Abstract] [Full Text] [Related]
4. Chronic myelomonocytic leukemia with der(9)t(1;9)(q11;q34) as a sole abnormality.
Suh B; Park TS; Kim JS; Song J; Kim J; Yoo JH; Choi JR
Ann Clin Lab Sci; 2009; 39(3):307-12. PubMed ID: 19667417
[TBL] [Abstract][Full Text] [Related]
5. Derivative (1;18)(q10;q10): a recurrent and novel unbalanced translocation involving 1q in myeloid disorders.
Wan TS; Ma SK; Au WY; Chan LC
Cancer Genet Cytogenet; 2001 Jul; 128(1):35-8. PubMed ID: 11454427
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetic and molecular aspects of Philadelphia negative chronic myeloproliferative disorders: clinical implications.
Panani AD
Cancer Lett; 2007 Sep; 255(1):12-25. PubMed ID: 17383090
[TBL] [Abstract][Full Text] [Related]
7. Karyotype and molecular cytogenetic studies in polycythemia vera.
Andrieux JL; Demory JL
Curr Hematol Rep; 2005 May; 4(3):224-9. PubMed ID: 15865876
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological features of unbalanced translocation Der(1;7)(q10;p10) in myeloid neoplasms.
So CC; Ma ES; Wan TS; Yip SF; Chan LC
Leuk Res; 2008 Jun; 32(6):1000-1. PubMed ID: 17980911
[No Abstract] [Full Text] [Related]
9. Conventional cytogenetics of myeloproliferative diseases other than CML contribute valid information.
Bacher U; Haferlach T; Kern W; Hiddemann W; Schnittger S; Schoch C
Ann Hematol; 2005 Apr; 84(4):250-7. PubMed ID: 15692838
[TBL] [Abstract][Full Text] [Related]
10. Pattern of trisomy 1q in hematological malignancies: a single institution experience.
Djordjević V; Dencić-Fekete M; Jovanović J; Drakulić D; Stevanović M; Janković G; Gotić M
Cancer Genet Cytogenet; 2008 Oct; 186(1):12-8. PubMed ID: 18786437
[TBL] [Abstract][Full Text] [Related]
11. Extra translocation +der(1q9p) is a prognostic indicator in myeloproliferative disorders.
Rege-Cambrin G; Speleman F; Kerim S; Scaravaglio P; Carozzi F; Dal Cin P; Michaux JL; Offner F; Saglio G; Van den Berghe H
Leukemia; 1991 Dec; 5(12):1059-63. PubMed ID: 1774954
[TBL] [Abstract][Full Text] [Related]
12. A case of chronic myeloproliferative syndrome followed by precursor T-cell acute lymphoblastic leukemia.
Bacher U; Haferlach T; Kern W; Harich HD; Schnittger S; Haferlach C
Cancer Genet Cytogenet; 2007 May; 175(1):52-6. PubMed ID: 17498558
[TBL] [Abstract][Full Text] [Related]
13. Gains on 9p are common genomic aberrations in idiopathic myelofibrosis: a comparative genomic hybridization study.
Al-Assar O; Ul-Hassan A; Brown R; Wilson GA; Hammond DW; Reilly JT
Br J Haematol; 2005 Apr; 129(1):66-71. PubMed ID: 15801957
[TBL] [Abstract][Full Text] [Related]
14. [Histopathology and molecular pathology of chronic myeloproliferative disorders].
Kreipe HH
Veroff Pathol; 1993; 141():1-158. PubMed ID: 8372486
[TBL] [Abstract][Full Text] [Related]
15. Deletion (11)(q13) as the sole anomaly in myeloid malignancies: four new cases and a short review.
Panani AD; Pappa V; Papageorgiou S; Stamatelli F; Raptis SA
Ann Hematol; 2004 Mar; 83(3):153-5. PubMed ID: 15064863
[TBL] [Abstract][Full Text] [Related]
16. Inv(1)(p22q25) in chronic myeloproliferative disease: constitutional or clonal defect?
Wong KF; Wong WC; Cheuk W
Cancer Genet Cytogenet; 2005 Apr; 158(2):188-91. PubMed ID: 15796968
[TBL] [Abstract][Full Text] [Related]
17. A der(18)t(9;18)(p13;p11) and a der(9;18)(p10;q10) in polycythemia vera associated with a hyperproliferative phenotype in transformation to postpolycythemic myelofibrosis.
Larsen TS; Hasselbalch HC; Pallisgaard N; Kerndrup GB
Cancer Genet Cytogenet; 2007 Jan; 172(2):107-12. PubMed ID: 17213018
[TBL] [Abstract][Full Text] [Related]
18. Inverted duplication dup(1)(q32q21) as sole aberration in lymphoid and myeloid malignancies.
Bacher U; Schnittger S; Grüneisen A; Haferlach T; Kern W; Haferlach C
Cancer Genet Cytogenet; 2009 Jan; 188(2):108-11. PubMed ID: 19100515
[TBL] [Abstract][Full Text] [Related]
19. [Karyotyping in chronic myeloproliferative syndrome (except chronic myeloid leukemia)].
Lessard M
Pathol Biol (Paris); 1982 Nov; 30(9):759-65. PubMed ID: 6760079
[TBL] [Abstract][Full Text] [Related]
20. Association of JAK2 mutation status and cytogenetic abnormalities in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms.
Dunlap J; Kelemen K; Leeborg N; Braziel R; Olson S; Press R; Huang J; Gatter K; Loriaux M; Fan G
Am J Clin Pathol; 2011 May; 135(5):709-19. PubMed ID: 21502425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
